Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7,4'-dihydroxyisoflavone-8beta-glucopyranoside
2. Kakonein
1. 3681-99-0
2. Kakonein
3. Daidzein-8-c-glucoside
4. 7-hydroxy-3-(4-hydroxyphenyl)-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
5. Puerarin 80 Mm
6. Chebi:8633
7. Npi 031g
8. Daidzein 8-c-glucoside
9. Nsc-380711
10. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
11. Z9w8997416
12. Puerarin, Analytical Standard
13. Mfcd00063399
14. Ac1nqz4n
15. 8-c-glucoside
16. 8-glucosyldaidzein
17. Unii-z9w8997416
18. Kudzu Root Extract
19. Nsc 380711
20. 7,4'-dihydroxy-8-c-glucosylisoflavone
21. Brn 0064198
22. 8-glucopyranosyldaidzein
23. Puerarin [inci]
24. Puerarin [who-dd]
25. Surecn8581666
26. 4-19-00-03200 (beilstein Handbook Reference)
27. Mls002473178
28. Bidd:er0101
29. Chembl486386
30. Schembl8581666
31. Hkeafjykmmkdor-vpricqmdsa-
32. Dtxsid30958020
33. Hms2198m10
34. Puerarin, >=98.0% (hplc)
35. Hy-n0145
36. Zinc4098745
37. Bdbm50129558
38. 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
39. Akos007930376
40. Akos015965556
41. Cs-6158
42. Db12290
43. Ks-5191
44. 4h-1-benzopyran-4-one, 8-beta-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-
45. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
46. Ac-20294
47. Smr001397270
48. N1114
49. 4',7-dihydroxy-8-c-glucosylisoflavone
50. Q63408673
51. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-chromen-8-yl]-d-glucitol
52. 4h-1-benzopyran-4-one, 8-.beta.-d-glucopyranosyl-7-hydroxy-3-(4-hydroxyphenyl)-
53. 8-(-bet.-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one
54. 8-(beta-d-glucopyranosyl-7-hydroxy-3- (4-hydroxyphenyl)-4h-1-benzopyran-4-one
55. (1s)-1,5-anhydro-1-[7-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-8-yl]-d-glucitol
56. 7-hydroxy-3-(4-hydroxyphenyl)-8-[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
Molecular Weight | 416.4 g/mol |
---|---|
Molecular Formula | C21H20O9 |
XLogP3 | 0 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Exact Mass | 416.11073221 g/mol |
Monoisotopic Mass | 416.11073221 g/mol |
Topological Polar Surface Area | 157 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 659 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?